Article
Interaction of implantable defibrillator therapy with angiotensin-converting enzyme deletion/insertion polymorphism.
Journal of cardiovascular electrophysiology - 1 Oct 2004
Bedi Maninder S, Postava Lisa A, Murali Srinivas, Macgowan Guy A, Mathier Michael, McNamara Dennis M, London Barry
Abstract excerpt
INTRODUCTION: The angiotensin-converting enzyme deletion allele (ACE D) decreases survival in patients with advanced heart failure. Whether the adverse impact on survival reflects an increased risk of pump failure or arrhythmic sudden death remains uncertain. If the ACE D genotype increases the risk of sudden death, implantable cardioverter defibrillator (ICD) therapy should diminish its negative impact. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
